Abbott Laboratories (ABT) Net Margin (2009 - 2026)
Abbott Laboratories (ABT) posted Net Margin of 7.37% for Q2 2026, down 23.61% sequentially from 9.65% in Q1 2026, and down 860.0% YoY from 0.97% in Q2 2025.
Abbott Laboratories (ABT) Net Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Net Margin for 18 years, with the latest figure at 7.37% in Q2 2026.
- Quarterly Net Margin fell 860.0% year-over-year to 7.37% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 11.65% (down 2078.0% YoY) and the FY2025 annual result came in at 14.72%, down 1723.0% from the prior year.
- Net Margin declined to 7.37% in Q2 2026 per ABT's latest filing, from 9.65% in the prior quarter.
- Over five years, Net Margin peaked at 84.1% in Q4 2024 and troughed at 7.37% in Q2 2026.
- A 5-year average of 17.76% and a median of 13.97% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2024 and 2025: Net Margin soared 6853 bps in 2024, then sank 6860 bps in 2025.
- Over 5 years, Net Margin stood at 10.24% in 2022, then soared by 52 bps to 15.56% in 2023, then jumped by 440 bps to 84.1% in 2024, then sank by 82 bps to 15.5% in 2025, then slumped by 52 bps to 7.37% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 7.37%, 9.65%, and 15.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 13.47% |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.37% |
| Mar 31, 2026 | 9.65% |
| Dec 31, 2025 | 15.50% |
| Sep 30, 2025 | 14.46% |
| Jun 30, 2025 | 15.97% |
| Mar 31, 2025 | 12.79% |
| Dec 31, 2024 | 84.10% |
| Sep 30, 2024 | 15.48% |
| Jun 30, 2024 | 12.55% |
| Mar 31, 2024 | 12.29% |
| Dec 31, 2023 | 15.56% |
| Sep 30, 2023 | 14.16% |
| Jun 30, 2023 | 13.78% |
| Mar 31, 2023 | 13.52% |
| Dec 31, 2022 | 10.24% |
| Sep 30, 2022 | 13.78% |
| Jun 30, 2022 | 17.93% |
| Mar 31, 2022 | 20.50% |
| Dec 31, 2021 | 17.27% |
| Sep 30, 2021 | 19.14% |